NCT05244226View on ClinicalTrials.gov

Pediatric Pain Optimization After Tonsillectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 8, 2022

Primary Completion Date

May 10, 2023

Study Completion Date

May 10, 2023

Conditions
Obstructive Sleep ApneaTonsillitisPain, Procedural
Interventions
DRUG

Fentanyl/Hydromorphone

Per routine care

DRUG

Methadone

Initial dosing 0.1mg/kg, potential to escalate to 0.15mg/kg following interim analysis

Trial Locations (1)

27710

Duke University School of Medicine, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT05244226 - Pediatric Pain Optimization After Tonsillectomy | Biotech Hunter | Biotech Hunter